2018 Speakers
Abizer Harianawala
Senior Director, Product Development & Technical Operations
TARIS Biomedical
Day Two
Thursday June 21, 2018
15.15 | Enhancing Communication During the Outsourcing Process & Beyond
Dean Calhoun
President & CEO
Affygility Solutions
Pre-Conference Workshop A
Tuesday June 19, 2018
08:00 | Establishing Practices to Work Effectively With & In Emerging Regions
Jacqui Van Sipe
Associate Director
EH&S, Vertex
Day One
Wednesday June 20, 2018
16.30 | Panel Discussion: Lessons Learned from Innovative Organizations in the Highly Potent Space
16.15 | Developing a Robust Occupational Toxicology Framework from Scratch in a Biotech Company Environment
Jay Brown
Senior EHSS Specialist
Alkermes
Day Two
Thursday June 21, 2018
14.15 | Best Practise Potent Compound Training: Understanding the Unique Training Requirements for Operators Handling HPAPIs
Richard Wooster
CSO
Tarveda Therapeutics
Day One
Wednesday June 20, 2018
16.30 | Panel Discussion: Lessons Learned from Innovative Organizations in the Highly Potent Space
16.00 | Pentarin Miniature Drug Conjugates: Targeting Potent Payloads to Tumors
Samuel Baron
Associate Director, Manufacturing Science & Technology
SK biotech Ireland
Day One
Wednesday June 20, 2018
11.45 | Operation of a Fully Integrated & Versatile HPAPI Manufacturing Facility
Marc Abromovitz
Head, Industrial Hygiene
Novartis
Day Two
Thursday June 21, 2018
15.45 | Panel Discussion: How Do You Decide on the Right CMO to Work With?
13.45 | Applying a Risk Based Approach for Defining Exposure Controls in the Workplace
Andrew Brewer
Senior Principal Engineer, Global Biologics Manufacturing Science & Technology
Genentech
Day One
Wednesday June 20, 2018
08.30 | Keynote Panel Discussion: Defining the Term – What Does ‘Highly Potent’ Actually Mean & Does it Matter?
Scott Duncan
Director of Chemistry, Technical Operations
Stealth Biotherapeutics
Day One
Wednesday June 20, 2018
16.30 | Panel Discussion: Lessons Learned from Innovative Organizations in the Highly Potent Space
Shaun Larsen
Director, Global EHS & Industrial Hygiene
Mylan
Day One
Wednesday June 20, 2018
11.15 | Highly Potent Containment & Controls in a Generics World
Timothy Maher
Associate Director, API Development & Commercialization
Merck
Day Two
Thursday June 21, 2018
15.45 | Panel Discussion: How Do You Decide on the Right CMO to Work With?
Reinhold Maeck
Head of Corp EHS Regulatory Intelligence
Boehringer Ingelheim
Pre-Conference Workshop B
Tuesday June 19, 2018
11.30 | Navigating the Potent Compound Regulatory Landscape
Day Two
Thursday June 21, 2018
09.00 | Evaluating Best-Practise Containment & Navigating the High Potent Regulatory Landscape from EHS to GMP
Scott Patterson
VP, Commercial Sales
ILC Dover
Day One
Wednesday June 20, 2018
14.15 | Interactive Panel Discussion: Cross-Disciplinary Perspectives on the Relative Benefits of Flexible vs Fixed Containment
13.15 | Flexible Containment Systems for Nanogram Level Containment
Paul Richards
Principal, Process Engineering
Biogen
Day Two
Thursday June 21, 2018
15.45 | Panel Discussion: How Do You Decide on the Right CMO to Work With?
10.00 | Case Study: Containment of a High Potency Sensitizer that Sublimes – Unique Challenges & Solutions
Bob Sussman
Managing Director
SafeBridge
Pre-Conference Workshop C
Tuesday June 19, 2018
15.00 | Comprehensive Occupational Exposure Banding: Insights For Handling Novel Potent Compounds
Day One
Wednesday June 20, 2018
17.00 | Chair’s Closing Remarks
08.30 | Keynote Panel Discussion: Defining the Term – What Does ‘Highly Potent’ Actually Mean & Does it Matter?
Day Two
Thursday June 21, 2018
16.15 | Chair’s Closing Remarks
08.50 | Chair’s Opening Remarks
Evan Thackaberry
VP, Nonclinical Development
Ra Pharmaceuticals
Day One
Wednesday June 20, 2018
16.30 | Panel Discussion: Lessons Learned from Innovative Organizations in the Highly Potent Space
John Roosa
Associate Director, New Technology Development & Industrial Hygiene Lead
Merck
Day One
Wednesday June 20, 2018
14.15 | Interactive Panel Discussion: Cross-Disciplinary Perspectives on the Relative Benefits of Flexible vs Fixed Containment
14.00 | A Hands-On Investigation of Potent Compound Handling Techniques
08.30 | Keynote Panel Discussion: Defining the Term – What Does ‘Highly Potent’ Actually Mean & Does it Matter?
Michael West
Director, Environment, Health & Safety
Pfizer
Day Two
Thursday June 21, 2018
11.30 | Continuous Processing: Unique Challenges Encountered in the Construction & Use of a Continuous Processing Suite
Andy Leyhane
Senior Research Scientist
AMRI
Day One
Wednesday June 20, 2018
09.15 | High Potent Capabilities & Case Studies at AMRI
Maurits Janssen
Head of Commercial Development
Lonza
Day Two
Thursday June 21, 2018
09.30 | Requirements for Fully-Integrated Service-Offerings in a HPAPI and Cytotoxic Environment
Tim Cowher
Managing Director
Kalyx Scientific
Day One
Wednesday June 20, 2018
13.45 | Investigating Task-Specific Flexible Containment Designs
Chris Rombach
President
ChargePoint Technology
Day Two
Thursday June 21, 2018
11.00 | HPAPI Contained Transfer Devices in a Risk-Based Era: Performance Validation Perspectives
James Lyon
Managing Director
SepSol
Day One
Wednesday June 20, 2018
15.45 | Zipping Through “Trics” for Flexible Containment of HPAPI : A Unique Approach
Mike Whaley
VP, EHS
Ipsen
Day Two
Thursday June 21, 2018
12.00 | Case Study: Ipsen Approach to Potent and Toxic Compound Management
Adam Kujath
Global Senior Director, Manufacturing Science and Technology
Alcami
